Intervencijska kardiologija jedno je od najbrže rastućih područja današnje medicinske znanosti, a tehnološka i farmakološka otkrića unutar tog područja unazad samo nekoliko godina dovela su do značajnih promjena u liječenju i prognozi bolesnika sa srčanožilnim bolestima. Prvenstveno je uloga intervencijske kardiologije u poboljšanju ishoda liječenja najjasnije vidljiva u akutnom koronarnom sindromu, a uspješne mreže primarne perkutane koronarne intervencije u akutnom infarktu miokarda predstavljaju jedno od najvećih dostignuća moderne kardiologije, a možda i medicine uopće. Dok je uloga intervencijske kardiologije u akutnoj koronarnoj bolesti jasna, stabilna koronarna bolest srca i dalje ostaje predmet javne rasprave te predmet brojnih istraživanja. Nove tehnologije i materijali u liječenju koronarne bolesti srca od 2012. postaju dostupne diljem svijeta, pa tako i u Hrvatskoj, a njihova implementacija isključivo ovisi o financijskim okolnostima. Novi antitrombocitni i antiagregacijski lijekovi također su predmet istraživanja, a sve u potrazi za (poželjno) jednim lijekom koji će u kardiovaskularnoj intervenciji imati najbolji omjer učinkovitosti i sigurnosti. Ova godina bila je i godina punog zamaha intervencijskog liječenja strukturne bolesti srca, napose aortne stenoze i mitralne regurgitacije, a kardioembolizacija, arterijska hipertenzija i periferna vaskularna bolest također postaju sve šire „igralište“ za intervencijske kardiologe. U ovom preglednom članku prikazali smo sve te moderne trendove u intervencijskoj kardiologiji protekle godine u svijetu i usporedili ih sa stanjem u Hrvatskoj.Interventional cardiology became among the fastest growing areas in clinical medicine, thanks to technological and pharmacological discoveries over the last few years, which brought important advancements in treatment and overall prognosis of patients with cardiovascular diseases. Benefits of primary interventional treatments became particularly evident in management of acute coronary syndrome, especially in circumstances of organized network of primary percuteneous coronary interventions, which represented crucial step in development of modern era in cardiology, or even medicine. On the other hand, interventional management of chronic ischemic heart disease recently came to greater focus of attention as the issue of professional challenge, due to exceedingly grown number of investigations. New technologies and devices for treatment of coronary artery disease become available in 2012 in the world market, as well as in Croatia. However, their implementation for the most depends on availability of financial resources. Further efforts were made around research on novel antiplatelet and antiaggregation drugs, with an aim to develop the agent that would preferably exert greater efficiency, within more favorable safety profile. This was the year in which interventional treatment extended on the structural heart diseases as well particularly due toincrease in treatment of aortic stenosis and mitral regurgitation, whilst cardioembolization, arterial hypertension and peripheral vascular disease become ever more attractive "battlefield" for interventional cardiologists. In this review article, we have presented all those modern trends in interventional cardiology in the past year at an international level and compared them to the situation in Croatia
